Tempest Therapeutics, Inc.
Datakwaliteit: 83%
TPST
Nasdaq
Manufacturing
Chemicals
€ 1,56
€ 0,00
(0,00%)
Marktkapitalisatie: 22,38 M
Prijs
€ 1,56
Marktkapitalisatie
22,38 M
Dagbereik
€ 1,55 — € 1,63
52-Weeksbereik
€ 1,50 — € 12,23
Volume
104.419
Openen € 1,56
50D / 200D Gem.
€ 2,26
31,00% below
50D / 200D Gem.
€ 6,08
74,34% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -26,82 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-325,65%
Onder sectorgemiddelde (-53,47%)
ROIC-135,68%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio2,30
Interest Coverage-128,38
Waardering
PE (TTM)
-0,85
Boven sectorgemiddelde (-1,47)
P/B Ratio3,53
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,9 | -1,5 |
| P/B | 3,5 | 1,6 |
| ROE % | -325,7 | -53,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -26,26 M |
| ROE | -325,65% | ROA | -126,22% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -26,82 M |
| ROIC | -135,68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,30 |
| Interest Coverage | -128,38 | Asset Turnover | N/A |
| Working Capital | 4,58 M | Tangible Book Value | 6,35 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,85 | Forward P/E | N/A |
| P/B Ratio | 3,53 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -119,86% | ||
| Market Cap | 22,38 M | Enterprise Value | 14,86 M |
| Per Share | |||
| EPS (Diluted TTM) | -6,33 | Revenue / Share | N/A |
| FCF / Share | -1,87 | OCF / Share | -1,87 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 102,12% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -26,26 M | -41,84 M | -29,49 M | -35,71 M | -28,30 M |
| EPS (Diluted) | -6,33 | -1,50 | -1,91 | -3,09 | -7,47 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -26,58 M | -42,03 M | -29,16 M | -34,64 M | -26,99 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 207.000,0 | 1,32 M | 1,45 M | 1,62 M | 1,28 M |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 16,93 M | 41,49 M | 51,60 M | 46,09 M | 73,24 M |
| Total Liabilities | 10,26 M | 22,36 M | 24,84 M | 27,98 M | 37,12 M |
| Shareholders' Equity | 6,67 M | 19,13 M | 26,77 M | 18,11 M | 36,12 M |
| Total Debt | — | 6,40 M | 10,50 M | 10,40 M | 15,07 M |
| Cash & Equivalents | 7,71 M | 30,27 M | 39,23 M | 31,23 M | 51,83 M |
| Current Assets | 8,27 M | 31,47 M | 40,36 M | 32,95 M | 68,96 M |
| Current Liabilities | 3,31 M | 14,22 M | 9,41 M | 7,28 M | 20,03 M |
{"event":"ticker_viewed","properties":{"ticker":"TPST","listing_kind":"stock","pathname":"/stocks/tpst","exchange":"Nasdaq","country":"US"}}